Phase III Study To Compare The Effect of Panzyga Versus Placebo in Patients With Pediatric Acute-onset Neuropsychiatric Syndrome (PANS/PANDAS)
Clinical trial NCT04508530 · COMPLETED
Trial details
- NCT number
- NCT04508530
- Sponsor
- Octapharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-30
- Primary completion
- 2024-08-27
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.